A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study
EuroIntervention · 2024
DOI: 10.4244/eij-d-24-00355 ↗Kurz gefasst
Fachartikel in der Zeitschrift EuroIntervention, 2024. Verfasst von Michael Haude und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic I, Rheinland Klinikum Neuss GmbH, Lukaskrankenhaus, Neuss, Germany. Hauptthemen laut MEDLINE: Magnesium, Absorbable Implants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Clinic I, Rheinland Klinikum Neuss GmbH, Lukaskrankenhaus, Neuss, Germany.
- Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland.
- Interventional Cardiology, MedStar Washington Hospital Center, Washington, D.C., USA.
Zitieren
APA
Haude, M., Iglesias, J. F., Garcia-Garcia, H. M., Barlagiannis, D., Degrauwe, S., Melaku, G., Beyene, S., & Waksman, R. (2024). A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study. EuroIntervention. https://doi.org/10.4244/eij-d-24-00355
Vancouver
Haude M, Iglesias JF, Garcia-Garcia HM, Barlagiannis D, Degrauwe S, Melaku G, et al. A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study. EuroIntervention. 2024. doi:10.4244/eij-d-24-00355
BibTeX
@article{Haude2024,
author = {Haude, Michael and Iglesias, Juan F and Garcia-Garcia, Hector M and Barlagiannis, Dimitrios and Degrauwe, Sophie and Melaku, Gebremedhin and Beyene, Solomon and Waksman, Ron},
title = {A new resorbable magnesium scaffold (DREAMS 3G): 12-month vasomotion results from the BIOMAG-I first-in-human study},
journal = {EuroIntervention},
year = {2024},
doi = {10.4244/eij-d-24-00355}
}
EUVIMED